top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

James B. Hawkins net worth and biography

James Hawkins Biography and Net Worth

Director of Iradimed

Mr. Hawkins previously served on our Board of Directors from 2013 to 2016. From 2004 to 2018. Mr. Hawkins was the President and Chief Executive Officer of Natus Medical, Inc., a leading manufacturer of medical devices and software and a service provider for the newborn care, neurology, sleep, hearing and balance markets. Currently he serves as a director of El Dorado Resorts Inc. and OSI Systems, Inc.

Prior to Natus, Mr. Hawkins was President, Chief Executive Officer, and a Director of Invivo Corporation, a provider of MRI-safe patient monitoring and the Chief Financial Officer of Sensor Control Corporation.

He earned his undergraduate degree in Business Commerce from Santa Clara University and holds a Masters of Business Administration degree from San Francisco State University.

What is James B. Hawkins' net worth?: The estimated net worth of James B. Hawkins is at least $1.67 million as of December 12th, 2023. Mr. Hawkins owns 39,348 shares of Iradimed stock worth more than $1,666,781 as of April 23rd. This net worth estimate does not reflect any other assets that Mr. Hawkins may own. Learn More about James B. Hawkins' net worth.
How do I contact James B. Hawkins?: The corporate mailing address for Mr. Hawkins and other Iradimed executives is 1025 Willa Springs Dr., Winter Springs FL, 32708. Iradimed can also be reached via phone at (407) 677-8022 and via email at [email protected]. Learn More on James B. Hawkins' contact information.
Has James B. Hawkins been buying or selling shares of Iradimed?: James B. Hawkins has not been actively trading shares of Iradimed during the last quarter. Most recently, James B. Hawkins sold 4,277 shares of the business's stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $44.58, for a transaction totalling $190,668.66. Following the completion of the sale, the director now directly owns 39,348 shares of the company's stock, valued at $1,754,133.84. Learn More on James B. Hawkins' trading history.
Who are Iradimed's active insiders?: Iradimed's insider roster includes Monty Allen (Director), James Hawkins (Director), Brent Johnson (VP), Christopher Scott (CFO), Roger Susi (CEO), and Anthony Vuoto (Director). Learn More on Iradimed's active insiders.
Are insiders buying or selling shares of Iradimed?: During the last year, insiders at the medical equipment provider sold shares 34 times. They sold a total of 199,374 shares worth more than $9,036,793.95. The most recent insider tranaction occured on December, 26th when CEO Roger E Susi sold 5,000 shares worth more than $230,000.00. Insiders at Iradimed own 42.6% of the company. Learn More about insider trades at Iradimed.
Information on this page was last updated on 12/26/2023.

James B. Hawkins Insider Trading History at Iradimed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/14/2023	Sell	4,277	$44.58	$190,668.66	39,348
12/12/2023	Sell	972	$43.40	$42,184.80	39,348
2/15/2022	Sell	9,441	$50.22	$474,127.02
12/7/2021	Sell	18,743	$47.07	$882,233.01
11/29/2021	Sell	12,176	$46.11	$561,435.36
11/26/2021	Sell	4,332	$44.00	$190,608.00
11/23/2021	Sell	6,038	$41.20	$248,765.60
8/11/2021	Sell	7,891	$35.20	$277,763.20	21,877
8/9/2021	Sell	4,609	$35.83	$165,140.47	21,877
11/25/2015	Sell	5,290	$30.98	$163,884.20	83,460
7/21/2014	Buy	80,000	$6.25	$500,000.00

James B. Hawkins Buying and Selling Activity at Iradimed

Iradimed Company Overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Today's Range

Now: $42.36

$40.82

$42.70

50 Day Range

MA: $43.05

$40.36

$46.76

2 Week Range

Now: $42.36

$36.12

$51.04

Volume

30,918 shs

Average Volume

51,555 shs

Market Capitalization

$536.28 million

P/E Ratio

31.15

Dividend Yield

1.46%

Beta

0.82